Kyung Bo Kim, PhD
Dr. Kim’s research lies at the interface between chemistry and biology. Specifically, the Kim lab focuses on the development and biological/pharmacological characterization of small molecule inhibitors targeting the proteasome-ubiquitin pathway.
Current research focuses on the development of immunoproteasome inhibitors that can be used as lead compounds in drug development process as well as molecule probes to investigate the function of the immunoproteasome.
Education & Appointments
- PhD Ohio State University, The
- MS Pohang University of Science & Technology
- BS Yonsei University
- Associate Professor, Department of Pharmaceutical Sciences